RBC Capital Maintains Outperform on Boston Scientific, Raises Price Target to $78
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh maintains an Outperform rating on Boston Scientific (NYSE:BSX) and raises the price target from $70 to $78.
April 15, 2024 | 6:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Shagun Singh maintains an Outperform rating on Boston Scientific and raises the price target from $70 to $78.
The increase in price target by RBC Capital reflects a positive outlook on Boston Scientific's stock, suggesting potential upside. This could lead to increased investor confidence and a possible short-term price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100